title: The preeminence of clusters.
abstract: Many cities and countries still view the foundation of a biotech sector as desirable for a high-tech, intellectually driven economy. But a discussion by seasoned biotech management and investors suggests that attaining an environment with the right mix of money, management and innovation remains a difficult and long-term challenge.
authors.affiliation: European Center of Pharmaceutical Medicine, University Hospital, Basel, Switzerland.
authors.forename: Fritz
authors.initials: F
authors.lastname: Bühler
authors.forename: C Mark
authors.initials: CM
authors.lastname: Tang
authors.forename: Pratik
authors.initials: P
authors.lastname: Shah
authors.forename: Mark
authors.initials: M
authors.lastname: Leuchtenberger
authors.forename: Ko-Chung
authors.initials: KC
authors.lastname: Lin
authors.forename: Pedro de Noronha
authors.initials: Pde N
authors.lastname: Pissarra
mesh_terms: D001709:Biotechnology / Q000191:economics* / Q000458:organization & administration*; D003132:Commerce; D019049:Developed Countries / Q000191:economics*; D007449:Investments